Kidney dosimetry in [177Lu]Lu-DOTA-TATE therapy based on multiple small VOIs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Kidney dosimetry in [177Lu]Lu-DOTA-TATE therapy based on multiple small VOIs

Published:2024-04 Issue: Volume:120 Page:103335
ISSN:1120-1797
Container-title:Physica Medica
language:en
Short-container-title:Physica Medica

Author:

Curkic Kapidzic Selma,Gustafsson Johan^ORCID,Larsson Erik^ORCID,Jessen Lovisa^ORCID,Sjögreen Gleisner Katarina

Publisher

Elsevier BV

Reference32 articles.

1. Patient-specific dosimetry in peptide receptor radionuclide therapy: a clinical review;Chalkia;Australas Phys Eng Sci Med,2015

2. Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study;Del Prete;Eur J Nucl Med Mol Imaging,2017

3. Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity;Garske-Román;Eur J Nucl Med Mol Imaging,2018

4. EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands;Sjögreen Gleisner;Eur J Nucl Med Mol Imaging,2022

5. Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points;Sandström;EJNMMI Phys,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3